Eliana Merle
Stock Analyst at UBS
(2.96)
# 1,478
Out of 4,910 analysts
86
Total ratings
42.86%
Success rate
0.85%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Eliana Merle
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SRPT Sarepta Therapeutics | Downgrades: Neutral | $45 → $12 | $13.32 | -9.91% | 1 | Jul 21, 2025 | |
| PROK ProKidney | Maintains: Buy | $4 → $8 | $3.22 | +148.45% | 1 | Jul 15, 2025 | |
| CVAC CureVac | Downgrades: Neutral | $12 → $5.5 | $5.46 | +0.73% | 3 | Jun 26, 2025 | |
| RAPT RAPT Therapeutics | Maintains: Neutral | $16 → $8 | $13.94 | -42.61% | 3 | May 22, 2025 | |
| ARVN Arvinas | Maintains: Buy | $74 → $21 | $7.88 | +166.67% | 4 | May 15, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $72 → $70 | $46.43 | +50.76% | 3 | May 13, 2025 | |
| MRNA Moderna | Maintains: Buy | $78 → $70 | $34.67 | +101.90% | 7 | May 2, 2025 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Buy | $441 → $458 | $306.76 | +49.30% | 4 | May 2, 2025 | |
| BBIO BridgeBio Pharma | Maintains: Buy | $65 → $72 | $46.19 | +55.88% | 3 | Apr 30, 2025 | |
| APLS Apellis Pharmaceuticals | Initiates: Overweight | $44 | $19.90 | +121.11% | 8 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $109 → $113 | $59.67 | +89.37% | 2 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $38 | $10.08 | +276.98% | 3 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $109 | $51.82 | +110.34% | 4 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $2.2 | $1.51 | +45.70% | 4 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $71 | $37.53 | +89.18% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $196 | $170.14 | +15.20% | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $10.82 | +158.78% | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $9.59 | +25.13% | 1 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $3 | $3.32 | -9.64% | 1 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $4.29 | +506.06% | 1 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $23 → $33 | $26.99 | +22.27% | 4 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $97 → $131 | $114.60 | +14.31% | 6 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $253 → $288 | $326.13 | -11.69% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3 → $5 | $6.90 | -27.54% | 3 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $18 | $6.09 | +195.57% | 2 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $42 | $15.38 | +173.08% | 4 | May 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $8 | $1.87 | +327.81% | 2 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $5.96 | +269.13% | 1 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $51 → $47 | $9.09 | +417.05% | 1 | Jun 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $6.31 | +153.57% | 2 | May 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $192 → $134 | $33.29 | +302.52% | 3 | Aug 19, 2020 |
Sarepta Therapeutics
Jul 21, 2025
Downgrades: Neutral
Price Target: $45 → $12
Current: $13.32
Upside: -9.91%
ProKidney
Jul 15, 2025
Maintains: Buy
Price Target: $4 → $8
Current: $3.22
Upside: +148.45%
CureVac
Jun 26, 2025
Downgrades: Neutral
Price Target: $12 → $5.5
Current: $5.46
Upside: +0.73%
RAPT Therapeutics
May 22, 2025
Maintains: Neutral
Price Target: $16 → $8
Current: $13.94
Upside: -42.61%
Arvinas
May 15, 2025
Maintains: Buy
Price Target: $74 → $21
Current: $7.88
Upside: +166.67%
Kymera Therapeutics
May 13, 2025
Maintains: Buy
Price Target: $72 → $70
Current: $46.43
Upside: +50.76%
Moderna
May 2, 2025
Maintains: Buy
Price Target: $78 → $70
Current: $34.67
Upside: +101.90%
Madrigal Pharmaceuticals
May 2, 2025
Maintains: Buy
Price Target: $441 → $458
Current: $306.76
Upside: +49.30%
BridgeBio Pharma
Apr 30, 2025
Maintains: Buy
Price Target: $65 → $72
Current: $46.19
Upside: +55.88%
Apellis Pharmaceuticals
Apr 29, 2025
Initiates: Overweight
Price Target: $44
Current: $19.90
Upside: +121.11%
Feb 20, 2025
Maintains: Buy
Price Target: $109 → $113
Current: $59.67
Upside: +89.37%
Jan 31, 2025
Maintains: Buy
Price Target: $25 → $38
Current: $10.08
Upside: +276.98%
Jan 31, 2025
Maintains: Buy
Price Target: $42 → $109
Current: $51.82
Upside: +110.34%
Jan 28, 2025
Maintains: Neutral
Price Target: $5 → $2.2
Current: $1.51
Upside: +45.70%
Jan 8, 2025
Maintains: Buy
Price Target: $65 → $71
Current: $37.53
Upside: +89.18%
Jan 7, 2025
Initiates: Buy
Price Target: $196
Current: $170.14
Upside: +15.20%
Jan 7, 2025
Initiates: Buy
Price Target: $28
Current: $10.82
Upside: +158.78%
Nov 12, 2024
Initiates: Buy
Price Target: $12
Current: $9.59
Upside: +25.13%
Nov 12, 2024
Initiates: Neutral
Price Target: $3
Current: $3.32
Upside: -9.64%
Nov 12, 2024
Initiates: Buy
Price Target: $26
Current: $4.29
Upside: +506.06%
Oct 30, 2024
Maintains: Neutral
Price Target: $23 → $33
Current: $26.99
Upside: +22.27%
Sep 18, 2024
Maintains: Neutral
Price Target: $97 → $131
Current: $114.60
Upside: +14.31%
Jun 28, 2024
Maintains: Buy
Price Target: $253 → $288
Current: $326.13
Upside: -11.69%
Apr 4, 2024
Maintains: Neutral
Price Target: $3 → $5
Current: $6.90
Upside: -27.54%
Mar 27, 2024
Maintains: Buy
Price Target: $19 → $18
Current: $6.09
Upside: +195.57%
May 19, 2023
Maintains: Buy
Price Target: $45 → $42
Current: $15.38
Upside: +173.08%
Dec 7, 2022
Maintains: Buy
Price Target: $19 → $8
Current: $1.87
Upside: +327.81%
Oct 13, 2022
Initiates: Buy
Price Target: $22
Current: $5.96
Upside: +269.13%
Jun 23, 2022
Maintains: Buy
Price Target: $51 → $47
Current: $9.09
Upside: +417.05%
May 21, 2021
Initiates: Buy
Price Target: $16
Current: $6.31
Upside: +153.57%
Aug 19, 2020
Maintains: Neutral
Price Target: $192 → $134
Current: $33.29
Upside: +302.52%